Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian T Hill

Showing results (11-20 of 167) with videos related to

Pageof 17
Sort By:
Transplantation and Cellular Therapy|July 3, 2023
Rush Hour Update: Roadblocks to CARs on the ExpresswayCraig S Sauter, Brian T Hill
Current Oncology Reports|April 4, 2019
The Emerging Role of Minimal Residual Disease Testing in Diffuse Large B-Cell LymphomaRachel Hu, Allison Winter, Brian T Hill
Clinical Pharmacokinetics|March 27, 2017
Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Chronic Lymphocytic Leukemia: Ibrutinib, Idelalisib, and VenetoclaxMadeline Waldron, Allison Winter, Brian T Hill
Journal of Pharmaceutical Sciences|March 28, 2007
Predicting human drug pharmacokinetics from in vitro permeability using an absorption-disposition modelKyle A Fliszar, Brian T Hill, Natalie Foster
Leukemia & Lymphoma|April 11, 2014
Complete remission of CD30-positive diffuse large B-cell lymphoma in a patient with post-transplant lymphoproliferative disorder and end-stage renal disease treated with single-agent brentuximab vedotinBrian T Hill, Raymond R Tubbs, Mitchell R Smith
Cell Death & Disease|November 9, 2021
Cooperative miRNA-dependent PTEN regulation drives resistance to BTK inhibition in B-cell lymphoid malignanciesIsha Kapoor, Juraj Bodo, Brian T Hill, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 24, 2025
SOHO State of the Art Updates and Next Questions | High-Grade B-Cell Lymphomas: Pathologic and Molecular Classification and Therapeutic ImplicationsRafaella Litvin, Agrima Mian, Sarah L Ondrejka, et al.
Transplantation and Cellular Therapy|April 30, 2021
Late Effects after Chimeric Antigen Receptor T cell Therapy for Lymphoid MalignanciesRajshekhar Chakraborty, Brian T Hill, Aneela Majeed, et al.
Blood Neoplasia|December 22, 2025
Deferring treatment in hairy cell leukemia: is active surveillance safe?Victoria M Rogness, Xuefei Jia, Wei Wei, et al.
Leukemia Research|October 1, 2023
Impact of active surveillance at time of diagnosis on overall survival in nodular lymphocyte-predominant Hodgkin lymphoma: A National Cancer Database studyVictoria M Rogness, Wei Wei, Matthew Cortese, et al.
Pageof 17

Showing results (11-20 of 167) with videos related to

Sort By:
Pageof 17
Transplantation and Cellular Therapy|July 3, 2023
Rush Hour Update: Roadblocks to CARs on the ExpresswayCraig S Sauter, Brian T Hill
Current Oncology Reports|April 4, 2019
The Emerging Role of Minimal Residual Disease Testing in Diffuse Large B-Cell LymphomaRachel Hu, Allison Winter, Brian T Hill
Clinical Pharmacokinetics|March 27, 2017
Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Chronic Lymphocytic Leukemia: Ibrutinib, Idelalisib, and VenetoclaxMadeline Waldron, Allison Winter, Brian T Hill
Journal of Pharmaceutical Sciences|March 28, 2007
Predicting human drug pharmacokinetics from in vitro permeability using an absorption-disposition modelKyle A Fliszar, Brian T Hill, Natalie Foster
Leukemia & Lymphoma|April 11, 2014
Complete remission of CD30-positive diffuse large B-cell lymphoma in a patient with post-transplant lymphoproliferative disorder and end-stage renal disease treated with single-agent brentuximab vedotinBrian T Hill, Raymond R Tubbs, Mitchell R Smith
Cell Death & Disease|November 9, 2021
Cooperative miRNA-dependent PTEN regulation drives resistance to BTK inhibition in B-cell lymphoid malignanciesIsha Kapoor, Juraj Bodo, Brian T Hill, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 24, 2025
SOHO State of the Art Updates and Next Questions | High-Grade B-Cell Lymphomas: Pathologic and Molecular Classification and Therapeutic ImplicationsRafaella Litvin, Agrima Mian, Sarah L Ondrejka, et al.
Transplantation and Cellular Therapy|April 30, 2021
Late Effects after Chimeric Antigen Receptor T cell Therapy for Lymphoid MalignanciesRajshekhar Chakraborty, Brian T Hill, Aneela Majeed, et al.
Blood Neoplasia|December 22, 2025
Deferring treatment in hairy cell leukemia: is active surveillance safe?Victoria M Rogness, Xuefei Jia, Wei Wei, et al.
Leukemia Research|October 1, 2023
Impact of active surveillance at time of diagnosis on overall survival in nodular lymphocyte-predominant Hodgkin lymphoma: A National Cancer Database studyVictoria M Rogness, Wei Wei, Matthew Cortese, et al.
Pageof 17